1. et al. Basiliximab reduces the rate and severity of acute rejection in adult liver transplant recipients [abstract 26]. Transplant 2000, Chicago, IL, May 13-17, 2000.
2. et al. Basiliximab reduces the rate/severity of acute rejection in adult liver transplant recipients [abstract 0292]. International Congress of the Transplantation Society, Rome, Italy, August 27-September 1, 2000.
3. ANTITHYMOCYTE GLOBULIN AS THE PRIMARY TREATMENT FOR RENAL ALLOGRAFT REJECTION
4. A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal Transplants